Tolvaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD): Efficacy and effects on quality of life. RSD [Internet]. 2025 May 14 [cited 2025 Dec. 5];14(5):e4914548812. Available from: https://rsdjournal.org/rsd/article/view/48812